132201-75-3

Basic information

• Product Name: 2,3,4,6-tetra-O-benzyl-D-glucopyranose trichloroacetimidate
• Synonyms: 2,3,4,6-tetra-O-benzyl-D-glucopyranose trichloroacetimidate
• CAS NO: 132201-75-3
• Molecular Weight: 685.044
• Mol File: 132201-75-3.mol
• Article Data: 37

Chemical Properties

• CAS DataBase Reference: 2,3,4,6-tetra-O-benzyl-D-glucopyranose trichloroacetimidate(CAS DataBase Reference)
• NIST Chemistry Reference: 2,3,4,6-tetra-O-benzyl-D-glucopyranose trichloroacetimidate(132201-75-3)
• EPA Substance Registry System: 2,3,4,6-tetra-O-benzyl-D-glucopyranose trichloroacetimidate(132201-75-3)

Safety Data

• Hazardous Substances Data: 132201-75-3(Hazardous Substances Data)

Upstream product

• 4132-28-9 2,3,4,6-tetra-O-benzyl-D-mannopyranose 
• 545-06-2 trichloroacetonitrile 
• 6386-24-9 2,3,4,6-tetra-O-benzyl-D-galactopyranose 
• 74666-83-4 1-deoxy-1-(S-ethyl)-2,3,4,6-tetra-O-benzyl-β-D-glucopyranoside 
• 7473-36-1 ethyl 1-thio-β-D-glucopyranoside 
• 32934-24-0 ethyl 2,3,4,6-tetra-O-acetyl-1-thio-β-D-glucopyranoside 
• 604-69-3 β-D-glucose pentaacetate 
• 100-39-0 benzyl bromide 
• 3879-79-6 methyl 2,3,4,6-tetra-O-benzyl-α-D-glucopyranoside 
• 97-30-3 methyl-alpha-D-glucopyranoside 
• 84799-77-9 methyl 2,3,4,6-tetra-O-benzyl-D-glucopyranoside 
• 97-30-3 methyl D-glucopyranoside 
• 2280-44-6 D-Glucose 
• 131531-76-5 p-methylphenyl 2,3,4,6-tetra-O-benzyl-thio-β-D-glucopyranoside 

Downstream Products

• 3879-79-6 (2R,3R,4S,5S,6S)-3,4,5-tris(benzyloxy)-2-((benzyloxy)methyl)-6-methoxytetrahydro-2H-pyran 
• 71526-33-5 methyl 2,3,4,6-tetra-O-benzyl-β-D-mannopyranoside 
• 83866-15-3 benzyl 2,3,4,6-tetra-O-benzyl-α-D-mannopyranosyl-(1->4)-2,3-di-O-isopropylidene-α-L-rhamnopyranoside 
• 148744-10-9 Diphenyl(2,3,4,6-tetra-O-benzyl-β-D-mannopyranosyl)phosphine Oxide 
• 38768-84-2 dibenzyl 2,3,4,6-tetra-O-benzyl-β-D-mannopyranosyl phosphate 
• 90357-98-5 dibenzyl 2,3,4,6-tetra-O-benzyl-α-D-mannopyranosyl phosphate 
• 149353-66-2 1,6-anhydro-4-O-(2,3,4,6-tetra-O-benzyl-α-D-mannopyranosyl)-2,3-O-isopropylidene-β-D-mannopyranose 
• 141118-12-9 2,3,4,6-tetra-O-benzyl-β-D-mannopyranosyl (benzyl 2,3,4-tri-O-benzyl-α-D-galactopyranosid)uronate 
• 103383-07-9 (3β,5β,14β,17β)-3β-<(2,3,4,6-tetra-O-benzyl-β-D-mannopyranosyl)oxy>-14-hydroxycard-20(22)-enolide 
• 103368-05-4 (3β,5β,14β,17β)-3β-<(2,3,4,6-tetra-O-benzyl-α-D-mannopyranosyl)oxy>-14-hydroxycard-20(22)-enolide 
• 58781-26-3 2,3,4,6-tetra-O-benzyl-D-glucopyranosyl-(1?1)-2,3,4,6-tetra-O-benzyl-D-glucopyranoside 
• 41736-89-4 3-O-(2,3,4,6-tetra-O-benzyl-β-D-glucopyranosyl)cholesterol 
• 70753-59-2 O-[2,3,4,6-tetra-O-benzyl-α-D-glucopyranosyl]cholesterol 

Relevant articles and documents

Decarboxylative glycosylation reaction - Intra- versus intermolecular reaction course

Mixed glycosyl carbonates are transformed under acid catalysis into glycosides. Competition experiments with equal amounts of carbonates 5 and 6 led to complete scrambling of the glycosyl donor and acceptor moieties: not only the expected glycosides 7 and

Stereoselective O-Glycosylations by Pyrylium Salt Organocatalysis**

Despite many years of invention, the field of carbohydrate chemistry remains rather inaccessible to non-specialists, which limits the scientific impact and reach of the discoveries made in the field. Aiming to increase the availability of stereoselective

Beta-D-glucose short-chain fatty acid ester compound as well as preparation method and application thereof

The invention discloses a beta-D-glucose short-chain fatty acid ester compound as well as a preparation method and application thereof, and belongs to the technical field of organic synthesis. The compound is a compound shown as a formula I, or a stereoisomer, a pharmaceutically acceptable salt, a solvate or a prodrug of the compound shown as the formula I. The formula is as shown in the description, wherein R is a methyl group, an ethyl group, a propyl group, a propylene group, an isopropylidene group, a butyl group, a butylidene group, an isobutylidene group, an amyl group, a pentylidene group or an isoamylidene group. The compound has potential prevention and treatment effects on diabetes, hyperlipidemia, atherosclerosis, Alzheimer's disease, cardiovascular and cerebrovascular diseases,inflammation, tumors and depression.

Visible-Light-Mediated β-C(sp3)-H Amination of Glycosylimidates: En Route to Oxazoline-Fused/Spiro Nonclassical Bicyclic Sugars

A straightforward route has been developed for the diastereoselective synthesis of nonclassical conformationally constrained oxazoline-fused and spiro bicyclic sugars bearing a quaternary center via selective β-C-H amination of appropriately positioned gl